Biologics Outsourcing Market Size, Share, Trends, Growth 2034

Biologics Outsourcing Industry Prospective

The global Biologics Outsourcing market was worth around USD 2.78 Billion in 2024 and is estimated to grow to about USD 6.61 Billion by 2034, with a compound annual growth rate (CAGR) of approximately 9.2% between 2025 and 2034

The report analyzes the Biologics Outsourcing market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Biologics Outsourcing market.

Biologics Outsourcing Market: Overview

Biologics Outsourcing services are expected to see a massive increase in popularity over the forecast period owing to rising investments in biotechnology research and development activities across the world. Biologics are drugs that are directly procured from living organisms and are extensively used in the treatment of multiple chronic diseases across the world.

These drugs are seeing a substantial increase in demand and are expected to be highly popular over the forecast period. They are also seeing an increase in use for the treatment of cardiovascular diseases which have massively increased in incidence over the past few years.

Biologics Outsourcing companies are expected to see good growth in business and revenue over the forecast period as the advancements in the healthcare sector boost. An increasing geriatric population is also expected to boost the market for Biologics Outsourcing over the forecast period.

Request Free Sample

Key Insights

• As per the analysis shared by our research analyst, the global biologics outsourcing market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2025-2034).
• Regarding revenue, the global biologics outsourcing market size was valued at around USD 2.78 Billion in 2024 and is projected to reach USD 6.61 Billion by 2034.
• The biologics outsourcing market is projected to grow at a significant rate due to increasing demand for biopharmaceuticals, rising costs of in-house drug development, growing adoption of contract manufacturing and research services, and advancements in biologics production technologies.
• Based on Type, the Antibodies segment is expected to lead the global market.
• On the basis of Source, the Human segment is growing at a high rate and will continue to dominate the global market.
• Based on the Application, the Stem Cell Research segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Biologics Outsourcing Market: Growth Drivers

Increasing Focus on Healthcare to Boost growth

Advancements in the healthcare industry have been prevalent across the world and this trend is expected to majorly boost the Biologics Outsourcing market potential over the forecast period. The Biologics Outsourcing market is also expected to be driven by the increasing prevalence of chronic diseases and rising instances of cancers, cardiovascular diseases, etc. increasing geriatric population across the world will also favor the Biologics Outsourcing market potential through 2028. Rising spending on research and development activities by healthcare companies and governments as well are expected to boost the Biologics Outsourcing market potential over the forecast period.

Global Biologics Outsourcing Market: Segmentation

The global Biologics Outsourcing market is segregated based on type, source, application, and region.

By type, the market is divided into Antibodies, Monoclonal Antibodies, Antibody Drug Conjugates, Others, Recombinant Proteins, Vaccines, and Others. The vaccine segment is anticipated to see high growth over the forecast period owing to the rising demand for vaccines for multiple diseases.

By Application, the Biologics Outsourcing market is segmented into Stem Cell Research, Vaccine Development, Tissue Related Products development, and Others. The stem cell research and vaccine development segments are projected to see high demand over the forecast period owing to rising investments in this sector by multiple healthcare companies and governments.

Biologics Outsourcing Market: Report Scope    

Recent Developments

• In 2019 – Bristol Meyers Squibb a leading name in the healthcare industry announced an investment of USD 900 million in its research and development division to advance research capabilities for multiple factors such as biologics as well.

Biologics Outsourcing Market: Regional Landscape

the presence of a developed healthcare infrastructure the Biologics Outsourcing market in North America is expected to hold a dominant outlook over the forecast period. Increasing investments on research and development activities in North America is expected to be a prominent driver through 2028. Rising support from the government, increasing adoption of technology in healthcare, favorable reimbursement initiatives, and increasing demand for quality diagnostics and treatment are other factors that will drive the Biologics Outsourcing market growth over the forecast period. The United States is anticipated to be the most lucrative country in this region through 2028. Europe is anticipated to follow North America and be the second largest market for Biologics Outsourcing in the global landscape. Increasing research and development activities will also favor Biologics Outsourcing market growth through 2028.

The Asia Pacific is anticipated to be the fastest-growing Biologics Outsourcing market in the global Biologics Outsourcing industry landscape over the forecast period.

Biologics Outsourcing Market: Competitive Landscape

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the biologics outsourcing market on a global and regional basis.

Some of the main competitors dominating the global Biologics Outsourcing market include –

• Catalent, Inc.
• Lonza Group AG
• Wuxi Biologics
• Boehringer Ingelheim
• Abzena Limited
• GL Biochem Corporation

Global Biologics Outsourcing market is segmented as follows:

By Type

• Antibodies
• Monoclonal Antibodies
• Antibody Drug Conjugates
• Recombinant Proteins
• Vaccines
• Others

By Source

• Human
• Microbial
• Others

By Application

• Stem Cell Research
• Vaccine Development
• Tissue Related Products development
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America